RA Capital
Joshua Resnick is a seasoned professional with extensive experience in both the financial and medical sectors. Currently serving as Senior Managing Director and Managing Director at RA Capital Management, L.P., Joshua also holds the positions of Chairman and CEO at Rheostat Therapeutics. In the medical field, Joshua is an Attending Physician in the Department of Emergency Medicine at Massachusetts General Hospital and Brigham and Women's Hospital. Additionally, Joshua contributes to academia as an Instructor at Harvard Medical School. Joshua completed medical education at the University of Pennsylvania School of Medicine and pursued business studies at The Wharton School.
RA Capital
2 followers
RA Capital Management® (“RA Capital”) is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics.